文献速递肾移植

肾移植后肾小球滤过率轨迹与进展至终末期肾病的关联

Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation.
PubMed 文献 · Kidney Int · 2020-08-08

该研究在15个学术中心对肾移植受者进行前瞻性eGFR监测,并在7项随机对照试验(共14132例患者、403497次eGFR测量)中验证,通过无监督潜在类别混合模型识别出8种不同的eGFR轨迹。中位随访6.5年,1688例患者进展至终末期肾病,eGFR轨迹与进展风险相关,且其决定因素和关联在不同队列和临床场景中一致。

要点

  • 肾移植后eGFR存在8种 distinct 轨迹,与进展至终末期肾病相关。
  • 供者年龄、eGFR、蛋白尿及组织学特征(移植物瘢痕、间质炎症等)是轨迹决定因素。
  • 轨迹模式在多个队列和随机对照试验中可重复,支持基于轨迹的风险分层。

核心结论

  • 肾移植后eGFR轨迹可识别8种不同模式,并与进展至终末期肾病相关。
  • 轨迹的决定因素包括供者年龄、eGFR、蛋白尿及多种组织学特征,且在多个队列中一致。

研究设计与样本

  • 前瞻性多中心观察性研究,纳入15个学术中心的肾移植受者,进行eGFR监测及临床、功能、组织学和免疫学评估。
  • 在7项随机对照试验(共14132例患者、403497次eGFR测量)中进行外部验证。

主要发现

  • 中位随访6.5年,1688例患者发生终末期肾病。
  • 通过无监督潜在类别混合模型识别出8种 distinct eGFR轨迹。
  • 多因素回归确定7个显著决定因素:供者年龄、eGFR、蛋白尿、移植物瘢痕、移植物间质炎症和肾小管炎、微循环炎症、循环抗HLA供者特异性抗体。
  • eGFR轨迹与进展至终末期肾病相关,且在不同队列、临床场景和治疗时代中相似。

关键数值与推荐

  • 识别出8种eGFR轨迹。
  • 7个显著决定因素包括供者年龄、eGFR、蛋白尿及组织学特征(移植物瘢痕、间质炎症和肾小管炎、微循环炎症)和循环抗HLA供者特异性抗体。
  • 中位随访6.5年,1688例发生终末期肾病。

临床怎么用

  • 可利用eGFR轨迹对肾移植患者进行风险分层和个体化监测。
  • 评估供者年龄、eGFR、蛋白尿及组织学特征有助于预测轨迹和终末期肾病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although the gold standard of monitoring kidney transplant function relies on glomerular filtration rate (GFR), little is known about GFR trajectories after transplantation, their determinants, and their association with outcomes. To evaluate these parameters we examined kidney transplant recipients receiving care at 15 academic centers. Patients underwent prospective monitoring of estimated GFR (eGFR) measurements, with assessment of clinical, functional, histological and immunological parameters. Additional validation took place in seven randomized controlled trials that included a total of 14,132 patients with 403,497 eGFR measurements. After a median follow-up of 6.5 years, 1,688 patients developed end-stage kidney disease. Using unsupervised latent class mixed models, we identified eight distinct eGFR trajectories. Multinomial regression models identified seven significant determinants of eGFR trajectories including donor age, eGFR, proteinuria, and several significant histological features: graft scarring, graft interstitial inflammation and tubulitis, microcirculation inflammation, and circulating anti-HLA donor specific antibodies. The eGFR trajectories were associated with progression to end stage kidney disease. These trajectories, their determinants and respective associations with end stage kidney disease were similar across cohorts, as well as in diverse clinical scenarios, therapeutic eras and in the seven randomized control trials. Thus, our results provide the basis for a trajectory-based assessment of kidney transplant patients for risk stratification and monitoring.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Raynaud M, Aubert O, Reese PP, et al. Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation. Kidney Int. 2020. PMID: 32781106. doi:10.1016/j.kint.2020.07.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。